Investigation of integron classes 1, 2, and 3 among multi-drug resistant Staphylococcus aureus isolates in Iran: a multi-center study Authors: Abolfazl Rafati Zomorodi, Mohammad Motamedifar, Karamatollah Rahmanian, Masihollah Shakeri, Bahareh Hajikhani, Hamid Heidari, Davood Mansury, Abdolreza Sotoodeh Jahromi Published: 2024 ABSTRACT AbstractBackgroundRising methicillin-resistant Staphylococcus aureus (MRSA) poses a global health threat, contributing to serious infections with high mortality rates. Integrons are recognized as significant genetic elements in disseminating multidrug-resistant (MDR) strains. This study focuses on assessing the prevalence of integron classes 1, 2, and 3 in S. aureus strains from four major cities in Iran.MethodsThis cross-sectional study analyzed 183 S. aureus isolates from Shiraz, Tehran, Isfahan, and Yazd in Iran. The isolates were identified using specific biochemical and molecullar tests. The Kirby-Bauer disc diffusion method and microbroth dilution method were employed to determine the susceptibility of the isolates to relevant antibiotics and vancomycin, respectively. The macrolide-lincosamide-streptogramin B (MLSB) resistance phenotype was also evaluated using the D-test. All isolates were sought for presence of the intI1, intI2, and intI3 genes.ResultsAmong 183 S. aureus isolates, high resistance rates were noted: 86.3% for erythromycin, 66.1% for ciprofloxacin, and 61.7% for clindamycin, while all isolates were susceptible to linezolid and vancomycin. Of the 183 isolates, 59.6% were identified as MRSA and 78.1% as MDR. According to the D-test results, 112/183 (61.2%), 29/183 (15.8%), 25/183 (13.7%), and 17/183 (9.7%) of S. aureus isolates showed constitutive resistance-MLSB, inducible resistance-MLSB, sensitive, and resistance to macrolide-streptogramin B (MS) phenotypes, respectively. The intI1 gene was found in 14 out of 183 S. aureus isolates (7.6%), while none were positive for the intI2 or intI3 genes. Notably, 11/14 (78.5%) and 13/14 (92.8%) intI1-positive isolates were MRSA and MDR, respectively.ConclusionsThe distribution of MRSA and MDR S. aureus isolates in Iran seems concerning. Although the prevalence of intI1 was not as high as in prior studies, almost all S. aureus harbored the intI1 gene were MRSA and MDR.Keywords: Integrons, Methicillin-resistant, Multiple-drug resistant, Staphylococcus aureus Introduction Staphylococcus aureus (S. aureus) is one of the most common colonizers of the human population. It is an opportunistic pathogen that causes severe infections with remarkably high mortality and morbidity [1]. Indeed, any physician or clinician, particularly those working in infectious diseases, will confirm the complexity and potential calamitousness of infections caused by this pathogen [2]. S. aureus is responsible for various infections, such as acne, folliculitis, abscesses, and wound infections. In addition, life-threatening infections can occur through S. aureus, including sepsis, osteomyelitis, toxic shock syndrome (TSS), bacteremia, and endocarditis [3]. Easily acquiring resistance to wide-spectrum antibiotic classes, comprising β-lactams, aminoglycosides, and macrolide-lincosamides-streptogramin B (MLSB) through mutation and horizontal gene transfer, introduced S. aureus into the list of high-priority antimicrobial-resistant bacteria by the World Health Organisation (WHO) [4–6]. Notably, methicillin-resistant S. aureus (MRSA) strains have emerged as a global concern since the 1990s, with a high spread among hospitalized patients and the community because MRSA strains are frequently resistant to most β-lactam antibiotics and identified as multi-drug-resistant (MDR) strains [7, 8]. Methicillin resistance occurs through a target modification mechanism, in this case, the mecA gene-mediated production of modified penicillin-binding protein 2a (PBP2a), which has a low affinity for β-lactam antibiotics [9]. Genomic analysis revealed that the mecA gene is on a mobile genetic element (MGE), the staphylococcal cassette chromosome mec (SCCmec) [10]. Numerous studies have examined various forms of SCCmec, resulting in the identification of XV types of SCCmec to date [9]. Furthermore, other MGEs such as plasmids, transposons, insertion sequences, chromosomal cassettes have been determined in S. aureus strains that play important role in developing MDR [11]. Integrons were introduced in the late 1980s, and nowadays, they are referred to as highlighted genetic structure development MDRs [12]. As an appropriate platform, they can capture, stockpile, recombinant, and facilitate the expression of promoterless gene cassettes containing various antimicrobial resistance genes [13]. Although integrons are not directly involved in horizontal gene transfer (HGT), they can become motionable through MGEs like conjugative plasmids and transposons [14]. Generally, the integrons structure is divided into three main sites as follows: an integrase gene (intI) that mediates producing integrase enzyme and a recombination site (attI) next to each other; the attC site that is frequently associated with a single open reading frame (ORF); and a gene cassette that is integrated between attI and attC sites [15]. Integrons are classified into four classes regarding divergences in the sequence of attI genes; integron classes 1, 2, and 3 are associated with antimicrobial resistance (AMR) [16]. Typically, researchers focus more on studying integrons in Gram-negative bacteria. However, studying integron classes among Gram-positive bacteria has become interesting in recent decades, particularly S. aureus strains [12]. Initial searches of previous investigations have revealed contradictory reports of the prevalence of integron classes among S. aureus trains. For instance, the frequency of integron class 1 was 0%—72% among S. aureus isolates in Iran [17–20]. Also, this controversy was observed among surveys in other countries: 42% in China [21], 71% in India [22], 46% in Egypt [23], and 0% in the USA [24]. The controversies among results published in earlier studies from Iran and other countries demonstrate that various factors, such as the implementation of antimicrobial stewardship, local antimicrobial consumption, and the predominant antibiotics prescribed by physicians in different geographical areas, affect the prevalence and distribution of S. aureus isolates that harbor integrons. Therefore, this study aimed to investigate the prevalence of integron classes 1, 2, and 3 among S. aureus isolates from four major cities in Iran. Furthermore, the correlation of carrying each tested integron with MRSA and MDR isolates was evaluated. Material and methods Sample collection We recruited a total of 183 S. aureus isolates from four cities in Iran, including 55/183 (30%) from Nemazee Hospital in Shiraz, 43/183 (23.5%) from hospitals affiliated with Shahid Beheshti University of Medical Sciences in Tehran; 45/183 (24.6%) from Shahid Sadoughi Hospital in Yazd; and 40/183 (21.9%) from Alzahra Hospital in Isfahan. Isolates were obtained during September, 2023 to March, 2024 from various clinical specimens of hospitalized patients, including blood, urine, sputum, wound, endotracheal tubes (ETT), etc. Identification of S. aureus All isolates were transferred to the Microbiology Laboratory of Medicine Faculty of Shiraz University of Medical Sciences in Shiraz. All S. aureus isolates were presumptively identified using conventional biochemical standard tests as follows: culturing onto the Blood Agar (producing β hemolysin) and Mannitol Salt Agar (fermented mannitol and tolerated salt), Gram staining, Catalase (+ ve) and Oxidase (-ve) tests, DNase (+ ve), and Coagulase (+ ve) tests (Merck, Germany). All identified S. aureus isolates were preserved at -70 °C in the Tryptic Soy Broth supplemented with 30% glycerol (Merck, Germany). DNA extraction DNA was extracted using a modified boiling method, as described in a previous study, specifically for Gram-positive bacteria [25]. Fresh subcultures were used, with 3–5 colonies collected and suspended in microtubes with 1 mL of sterile ultrapure water. The samples were centrifuged at 6000 g for 3 min, and the resulting pellets were washed with 1 mL of 1X Tris–EDTA (Merck, Germany) buffer. Following this, 500 µL of sterile ultrapure water was added, and the microtubes were immediately placed in a water bath at 95 ℃ for 10 min, followed by a 5-min incubation in an ice box. Subsequently, the samples were centrifuged at 8000 rpm for 5 min in a microcentrifuge (Sigma 1–14, Germany), and 100 µL of the supernatant was carefully removed for purity assessment. The A260/A280 and A230/A280 ratios were determined using a Nanodrop 2000 UV–Vis spectrophotometer (Thermo Scientific, USA) to evaluate purity. Molecular identification of S. aureus All presumptively identified S. aureus isolates were confirmed by amplifying the nuc gene using polymerase chain reaction (PCR). The previously designed primers were used [26]; the sequence of oligonucleotide primers was nuc-F (5’-GCGATTGATGGTGATACGGTT-3’) and nuc-R (5’-AGCCAAGCCTTGACGAACTAAAGC-3’). The PCR was started with initial denaturation at 95 °C for 5 min, continuing with 35 cycles of denaturation at 95 °C for 45 s, annealing at 58 °C for 45 s, and extension at 72 °C for 1 min; at the end, final extension at 72 °C for 5 min. The S. aureus ATCC 25923 strain and distilled water (used in place of the DNA template) implied as positive and negative controls, respectively. Antimicrobial susceptibility testing The Kerby-Bauer disc diffusion method, as recommended by CLSI 2024 [27], was conducted to investigate the susceptibility of S. aureus isolates against nine antibiotics, comprising cefoxitin (FOX, 30 µg), erythromycin (ERY, 15 µg), clindamycin (CLD, 2 µg), ciprofloxacin (CIP, 5 µg), rifampin (RIF, 5 µg), tetracycline (TET, 30 µg), gentamicin (GEN, 10 µg), linezolid (LZD, 30 µg), chloramphenicol (CHL, 30 µg), and trimethoprim/sulfamethoxazole (1.25/23.75 µg) (Mast group, UK). In addition, susceptibility to vancomycin was evaluated using vancomycin (Sigma-Aldrich Co., St Louis, MO, USA) and the microbroth dilituion method; the MIC range was prepared from 0.125 µg/mL to 64 µg/mL. The eleventh and twelfth columns of the 96-well microtiter plate were filled with Enterococcus faecalis ATCC 52299 and Mueller Hinton broth (Merck, Germany) without bacteria, respectively, serving as positive and negative controls. The S. aureus ATCC 25923 strain was implied as quality control. MRSA isolates were determined through evaluation of susceptibility against cefoxitin (FOX, 30µg) disc; resistant isolates (inhibition zone ≤ 21) were considered MRSA [27]. MDR isolates were defined as previously described [28]; specifically, these bacterial isolates exhibited resistance to at least one antibiotic from three or more different classes. MLSB resistance phenotypes The D-test was performed to determine inducible clindamycin resistance among S. aureus isolates. According to CLSI, 2024; Briefly, ERY, and CLD discs were placed next to each other (with a 20 mm distance) onto the fresh S. aureus cultured on the Muller-Hinton agar plates incubated at 35 ± 2 ℃ for 18–20 h. Table 1 represents the interpretation results [29]. Table 1D-test interpretation and determine MLSB phenotypes resistance MLSB phenotype Susceptibility result Phenotype description ERY CLD cMLS B RRGrowth around ERY and CLD discs iMLSB RSGrowing around the ERY disc and displaying a D shape clear zone around CLD MS RSGrowing around ERY disc, but no Growth around CLD disc Sensitive SSInhibition zone around ERY and CLD discs Abbreviation: ERY erythromycin, CLD clindamycin, cMLSB constitutive resistance to macrolide-lincosamide-streptogramin B, iMLSB inducible resistance to macrolide-lincosamide-streptogramin B, MS resistace to macrolide-streptogramin B D-test interpretation and determine MLSB phenotypes resistance Abbreviation: ERY erythromycin, CLD clindamycin, cMLSB constitutive resistance to macrolide-lincosamide-streptogramin B, iMLSB inducible resistance to macrolide-lincosamide-streptogramin B, MS resistace to macrolide-streptogramin B Molecular detection of MRSA The mecA gene was amplified to confirm MRSA isolates. In this regard, the MRSA isolates were subjected based on the phenotypic experiment (resistant to cefoxitin). The primer sequences of the mecA gene were mecA-F (5’-GTAGAAATGACTGAACGTCCGATAA-3’) and mecA-R (5’-CCAATTCCACATTGTTTCGGTCTAA-3’) [26]. The PCR condition was the same as explained for the nuc gene. Molecular detection of three integron classes All S. aureus isolates were subjected to amplification of intI1, intI2, and intI3 was performed using previously designed specific primers [30, 31]. The oligonuleutide sequence of primers were as follow: F-5’-CCTCCCGCACGATGATC-3’ and R-5’-TCCACGCATCGTCAGGC-3’ for intI1, F-5’-TTATTGCTGGGATTAGGC-3’ and R-5’-ACGGCTACCCTCTGTTATC-3’ for intI2, F-5’-AGTGGGTGGCGAATGAGTG-3’ and R-5’- TGTTCTTGTATCGGCAGGTG-3’ for intI3. The PCR reaction was prepared in 25 µL final volume containing 12.5 μL of PCR 2 × Master Mix (Amplicon, Denmark), 1 μL of each primer (10 μM), 2 μL of template DNA (100 ng/µL), and 8.5 µL of nuclease-free water. The PCR amplification was established using the Veriti™ 96-Well Thermal Cycler (Applied Biosystems, USA); the condition was started with initial denaturation at 95 ℃ for 4 min, continuous with 35 cycles of denaturation at 95 ℃ for 45 s, annealing at 58 ℃ for 45 s, and 1 min for extension; eventually, final extension was accomplished at 72 ℃ for 5 min. Statistical analysis The statistical analysis in this study utilized SPSS™ 22.0 (SPSS Inc., Chicago, Illinois, USA). The evaluation was conducted using Chi-square and Fisher’s exact test, with a statistical significance of p < 0.05. Results Demographic Of the 183 tested S. aureus isolates in the present study, 99 (54.1%) and 84 (45.9%) were obtained from males and females, respectively; the age of patients who participated was 1 to 90 years old, with a mean age of 48.66 (± 1.55) years. The most frequent specimens that S. aureus was isolated from were blood 51 (27.9%), wound 31 (16.9%), urine 27 (14.8%), sputum 25 (13.7%), and ETT 20 (10.9%), respectively. Also, in terms of wards, the highest frequency of S. aureus isolates was detected in ICU 54 (29.5%), internal 36 (19.7%), emergency 24 (13.1%), and surgery 24 (13.1%) (Table 2). Table 2Demographic information of S. aureus isolates studied in the current study (N = 183) Demographic Shiraz No. (%) Tehran No. (%) Yazd No. (%) Isfahan No. (%) Total No. (%) Gender Male 27 (27.3%)24 (24.2%)25 (25.3%)23 (23.2%)99 (100%) Female 28 (33.4%)19 (22.6%)20 (23.8%)17 (20.2%)84 (100%) Wards ICU 20 (37.1%)14 (25.9%)6 (11.1%)14 (25.9%)54 (100%) Internal 10 (27.7%)10 (27.7%)9 (25%)7 (19.6%)36 (100%) Emergancy 5 (20.8%)5 (20.8%)8 (33.4%)6 (25%)24 (100%) Pediatric 9 (69.2%)1 (7.7%)3 (23.1%)-13 (100%) Infectious 1 (6.2%)4 (25%)9 (56.3%)2 (12.5%)16 (100%) Surgery 3 (24.5%)6 (25%)7 (29.1%)8 (33.4%)24 (100%) Acute 7 (43.9%)3 (18.7%)3 (18.7%)3 (18.7%)16 (100%) Specimens Blood 17 (33.3%)14 (27.5%)13 (25.4%)7 (13.8%)51 (100%) Urine 5 (18.5%)11 (40.7%)3 (11.1%)8 (29.7%)27 (100%) Wound 3 (9.6%)6 (19.4%)15 (48.5%)7 (22.5%)31(100%) Sputum 14 (56%)5 (20%)4 (13%)2 (8%)25 (100%) ETT 7 (35%)2 (10%)4 (20%)7 (35%)20 (100%) Abscess 1 (14.2%)1 (14.2%)1 (14.2%)4 (57.2%)7 (100%) Nasal 2 (33.3%)1 (16.6%)2 (33.3%)1 (16.6%)6 (100%) Pleural 2 (25%)2 (25%)1 (12.5%)3 (37.5%)8 (100%) Auxilary 1 (100%)---1 (100%) CSF 1 (100%)---1 (100%) Fluid 2 (33.3%)1 (16.6%)2 (33.3%)1 (16.6%)6 (100%) Abbreviation: ICU intensive care unit, ETT endotracheal tube Demographic information of S. aureus isolates studied in the current study (N = 183) Abbreviation: ICU intensive care unit, ETT endotracheal tube Antimicrobial susceptiblity testing The highest resistance was against erythromycin, ciprofloxacin, and clindamycin, with a frequency of 158/183 (86.3%), 121/183 (66.1%), and 113/183 (61.7%), respectively. All isolates were susceptible to linezolid and vancomycin. Out of 183 S. aureus isolates, 109 (59.6%) were identified as MRSA, based on their resistance to cefoxitin and the presence of the mecA gene. Additionally, 143 out of 183 (78.1%) S. aureus isolates were determined to be MDR (Fig. 1). The highest prevalence of MRSA was observed among isolates from Isfahan (37/40, 92.5%), followed by Tehran (38/43, 88.4%), Shiraz (21/55, 38.2%), and Yazd (16/45, 35.6%). Furthermore, the highest frequency of MDR isolates was found in Tehran (40/43, 93%), followed by Yazd (38/45, 80%), Shiraz (39/55, 70.9%), and Isfahan (28/40, 70%). The statistical analysis revealed a significant prevalence of MRSA isolates in Tehran and Isfahan compared to methicillin-sensitive S. aureus (MSSA) isolates (33.9% vs. 7% and 33% vs. 4.2%; p < 0.001, respectively). Additionally, the prevalence of MDR and non-MDR isolates was significant only in Tehran (28% vs. 7.5%; p = 0.02). The prevalence of resistance to erythromycin, ciprofloxacin, gentamicin, rifampin, and tetracycline showed significant differences among MRSA and MSSA isolates (63.9% vs. 44%) p = 0.01, (66.9% vs. 50.8%) p = 0.02, (89.8% vs. 50.8%) p < 0.001, (84.8 vs. 52.6%) p < 0.001, (70.2% vs. 43.5%) p = 0.001, respectively (Table 3). Prevalence of resistance to tested antibiotics, MRSA, and MDR S. aureus isolates among different cities in Iran (N = 183). Abbreviations: SXT, terimethoprime/sulfamethoxazole; ERY, erythromycin; CLD, clindamycin; CIP, ciprofloxacin; GEN, gentamicin; RIF, rifampin; CHL, cloramphenicol; TET, tetracycline; MRSA, methicillin-resistant S. aureus; MDR, multi-drug resistant Table 3Prevalence of MRSA and MSSA isolates accordance with antimicrobial resistance pattern Antibiotics MRSA No. (%) MSSA No. (%) p value * FOX ( N = 109) 109 (100%)0-** ERY ( N = 158) 100 (63.2%)58 (36.8%) 0.01 CLD ( N = 112) 68 (60.7%)44 (39.3%)0.69 CIP ( N = 121) 80 (66.1%)41 (33.9%) 0.02 GEN ( N = 49) 43 (87.7%)6 (12.3%) < 0.001 CHL ( N = 37) 22 (59.4%)15 (40.6%)0.98 TET ( N = 121) 83 (68.6%)38 (31.4%) 0.01 RIF ( N = 46) 39 (84.7%)7 (15.3%) < 0.001 SXT ( N = 104) 60 (57.7%)44 (42.3%)0.5 Abbreviations: FOX cefoxitin, ERY erythromycin, CLD clindamycin, CIP ciprofloxacin, GEN gentamicin, RIF rifampin, CHL cloramphenicol, TET tetracycline, SXT terimethoprime/sulfamethoxazole, MRSA methicillin-resistant S. aureus, MSSA methicillin-sensitive S. aureus * p value < 0.05 is significant **It is not calculable Prevalence of MRSA and MSSA isolates accordance with antimicrobial resistance pattern Abbreviations: FOX cefoxitin, ERY erythromycin, CLD clindamycin, CIP ciprofloxacin, GEN gentamicin, RIF rifampin, CHL cloramphenicol, TET tetracycline, SXT terimethoprime/sulfamethoxazole, MRSA methicillin-resistant S. aureus, MSSA methicillin-sensitive S. aureus * p value < 0.05 is significant **It is not calculable MLSB resistance phenotypes According to the D-test results, 112/183 (61.2%), 29/183 (15.8%), 25/183 (13.7%), and 17/183 (9.7%) of S. aureus isolates showed constitutive MLSB resistance (cMLSB), inducibale MLSB resistance (iMLSB), sensitive, and resistace to macrolide-streptogramin B (MS) phenotypes, respectively. Of 29 S. aureus isolates with the iMLSB phenotype, 19 (65.5%) and 18 (62.1%) were MRSA and MDR, respectively. Although there was not a significant correlation between different MLSB resistance phenotypes in MRSA isolates (p = 0.17), significant differences were determined between MLSB resistance phenotypes and MDR isolates (p < 0.001). Figure 2 shows the frequency of different MLSB resistance phenotypes in different cities. The prevalence of MLSB phenotypes among S. aureus isolates in different cities in Iran (N = 183). Abbreviations: cMLSB, constitutive resistance to macrolide-lincosamide-streptogramin B; iMLSB, inducible resistance to macrolide-lincosamide-streptogramin B; MS, resistance to macrolide-streptogramin B Molecular detection of three integron classes Generally, the intI1 gene was detected in 14/183 (7.6%) of S. aureus isolates; also, none of the subjected S. aureus isolates were positive for the intI2 and intI3 genes (Fig. 3). Most of these 14 S. aureus isolates were isolated from Tehran (11/14, 78.5%), followed by Isfahan (2/14, 14.2%), and Shiraz (1/14, 7.1%); there was no positive S. aureus isolate harboring intI1 gene from Yazd. Remarkably, 11, 13, and 12 out of 14 positive S. aureus isolates for the intI1 gene were MRSA, MDR, and cMLSB (Fig. 4). No significant differences were found in the prevalence of MDR and non-MDR isolates (9.1% vs. 2.5%; p = 0.16), as well as MRSA and MSSA isolates (10.1% vs. 4.1%; p = 0.13) among S. aureus isolates harboring intI1 gene. The PCR amplified products were displayed using agarose gel electrophoresis (1.5% agarose). Lane M: DNA marker (100 bp DNA Ladder); Lane C-: negative control; Lane C + : positive control including intI1 (280 bp), intI2 (233 bp), and intI3 (600 bp) genes; Lanes 2, 4, and 8: detection of intI1 gene Charachtrizing of 14 intI1-positive S. aureus isolates regarding their demographic and antimicrobial susceptibility testing results. SXT, terimethoprime/sulfamethoxazole; ERY, erythromycin; CLD, clindamycin; CIP, ciprofloxacin; GEN, gentamicin; RIF, rifampin; CHL, cloramphenicol; TET, tetracycline; MRSA, methicillin-resistant S. aureus; MDR, multi-drug resistant; ICU, intensive care unit; iMLSB, inducible resistance to macrolide-lincosamide-streptogramin B Discussion Given the increasing antimicrobial resistance in bacteria, particularly S. aureus isolates, screening susceptibility to commonly chosen antibiotics is critical as an empirical treatment [23]. The global threat posed by increasing MRSA isolates persists, with MRSA-mediated infections posing a life-threatening worldwide. Also, the prevalence of MRSA remains an essential indicator for assessing infection control measures and prevention practices [32, 33]. The results showed that 109/183 (59.6%) S. aureus isolates contained MRSA isolates, with the majority occurring in Isfahan (37/40, 92.5%) and Tehran (38/43, 88.4%), respectively. In contrast, the prevalence of MRSA isolates in Shiraz (21/55, 38.2%) and Yazd (16/45, 35.6%) was significantly lower compared to Tehran and Isfahan (p < 0.001). Our findings revealed a prevalence of MRSA (59.6%) and MDR (78.1%) in S. aureus isolates, indicating a higher prevalence of MDR in comparison with a prior study by Mohammadi et al. that subjected S. aureus isolates from different provinces (Isfahan, Kashan, Qom, and Tehran) in Iran. Their results showed a prevalence of MRSA and MDR S. aureus isolates in the range of 59.1% and 61.1%, respectively [20]. However, in recent studies in Tabriz, Kerman, Tehran, and Birjand, the frequency of MRSA and MDR S. aureus isolates was 40.8% and 68.2%, 57.1% and 56.6%, 37.5% and 48.5%, and 44% and 39.4%, respectively, which was lower than the current study [34–36]. Although several factors contribute to these discrepancies (including different sample sizes, variations in geography, etc.), the prevalence of infection control and prevention in Iran requires revision. Integrons are genetic structures that hold gene cassettes with antibiotic resistance genes. They are linked to MDR and restrict treatment options, making clinical outcomes worse [18]. In the current study, 14/183 (7.5%) of the S. aureus isolates showed the presence of intI1. This frequency was lower than previous reports in Iran and other countries, 31%–56% [17, 20, 21, 37]. Several factors contribute to this controversy; perhaps one of the most significant is related to the DNA extraction methods used for Gram-positive bacteria in different surveys. In the present investigation, DNA extraction was performed using a modified boiling method [25], as previously explained. Additionally, there are other modified extraction methods for Gram-positive bacteria such as S. aureus. Therefore, it seems that further investigation aimed at comparing results from the same sample size using different extraction methods would be beneficial [38]. However, intrestingly most of containing intI1 S. aureus isolates were MRD and MRSA that sopused role of integrons in developing MDR and MRSA isolates. Nevertheless, the statistical analysis of the results in the present study did not reveal a positive correlation between MRSA and MDR S. aureus isolates and those containing the intI1 gene. As predicted, MRSA strains typically resist macrolides, lincosamides, aminoglycosides, and nearly all beta-lactam antimicrobial agents presently accessible, including penicillin and cephalosporins [12, 39]. Our experiment demonstrated that more than half of the resistant S. aureus isolates to erythromycin, clindamycin, trimethoprim/sulfamethoxazole, and chloramphenicol were MRSA. However, there was no significant correlation between MRSA and being resistant to these antibiotics. Further, resistance to ciprofloxacin, gentamicin, rifampin, and tetracycline was significantly associated with MRSA (p < 0.05). These observations reinforce previous scenarios that describe infection by MRSA isolates as more severe and complicated to treat compared to MSSA isolates [40, 41]. Although MLSB group antibiotics are chemically and structurally distinguishable, they all prevent protein synthesis by binding to the 23S rRNA of the 50S ribosomal subunit [42]. Among the three major mechanisms of resistance to MLSB group antibiotics—efflux pump activation, enzymatic antibiotic inactivation, and target alteration—only the latter confers resistance against all members of this group [43]. S. aureus isolates exhibiting the cMLSB phenotype are resistant to all macrolides, lincosamides, and streptogramin B, a resistance that occurs due to rRNA methylation [44]. On the other hand, S. aureus isolates with the iMLSB phenotype are resistant to erythromycin and may be inaccurately classified as sensitive to clindamycin. This occurs because erythromycin acts as an inducer, leading to the production of rRNA methylase [42]. Therefore, almost all infections caused by iMLSB phenotype isolates fail with empirical therapy using clindamycin [45]. Thus, a treatment strategy for infections caused by Staphylococcus aureus isolates requires D-test evaluation. The current study found that 112/183 (61.2%) and 29/183 (15.8%) of S. aureus isolates had cMLSB and iMLSB prevalence, respectively. These findings differ from earlier investigations in Iran that reported incidences of cMLSB and iMLSB in the range of 22.9%–38.9% and 13.5%–22.2% [46–48]. However, Tanabandeh et al. indicated similar results in the prevalence of cMLSB (61.1%) and iMLSB (22.2%) [49]. The prevalence of the iMLSB resistance phenotype in this study surpassed that reported in previous studies conducted in Iran. This may suggest a potential increase in erythromycin consumption in Iran. Although there were no significant differences among MRSA and MLSB resistance phenotypes, 69/112 (61.6%) and 19/29 (65.5%) of S. aureus isolates with cMLSB and iMLSB resistance phenotypes were MRSA, respectively. However, a significant correlation was recorded between S. aureus isolates with the cMLSB resistance phenotype and those with MDR (p < 0.001). Therefore, the third generation of macrolides or new ketolides, such as telithromycin, solithromycin, and cethromycin, could be an appropriate treatment choice. However, further investigations are suggested to represent their antibacterial activity and provide helpful information about how they influence the erm gene expression [50]. Ultimately, our work has some limitations. Although the four chosen cities are the most important medical referral centers in Iran, they do not encompass all regions of Iran. Therefore, given the small sample size, caution must be exercised when interpreting the findings of the current study, as they may not be applicable to all regions of Iran. Conclusion In summary, the distribution of MRSA and MDR S. aureus isolates in Iran seems concerning. Also, in addition to the increasing rate of cMLSB and iMLSB resistance phenotypes compared to previous investigations in Iran and other countries, a significant relationship between these phenotypes and MRSA and MDR S. aureus isolates led to failure in treatment. Although the prevalence of intI1 was not as high as in prior studies, almost all S. aureus harbored the intI1 gene, were MRSA and MDR. Therefore, eliminating integrons, particularly type 1, may be important in developing MRSA and MDR isolates. Eventually, these findings underscore the ongoing problem of antibiotic resistance and necessitate reevaluating strategies for managing S. aureus infections in Iran. Acknowledgements All authors would like to thank the staff at Nemazee, Alzahra, Shahid Sadoughi, and Shahid Behshti Hospitals for their cooperation. Abbreviations Staphylococcus aureus Toxic shock syndrome Macrolide-lincosamides-streptogramin B World Health Organization Methicillin-resistant S. aureus Multi-drug resistant Penicillin-binding protein 2a Mobile gene element Staphylococcal cassette chromosome mec Horizontal gene transfer Open reading frame Antimicrobial resistance Tndotraceal tube Polymerase chain reaction Authors’ contributions A.R.Z. contributed to study design, conceptualization, and writing draft of manuscript. K.R. and M.Sh performed laboratory experiments, data analysis. M.M., B. H., H.H, and D.M. contributed to data collection, visualization, data interpretation and data visualization. A.S.J. contributed to the study design and critical revision of the manuscript. All authors have critically reviewed and given approval to the final version of the manuscript for submission. Funding This work was made possible by the Vice-Chancellor for Research at Jahrom University of Medical Sciences. The grant number is IR.JUMS.REC.401000222. Data availability The datasets created and examined for this research can be obtained by reaching out to the corresponding author. Declarations Ethics approval and consent to participate The Ethics Committee of Jahrom University of Medical Sciences gave their approval for this study with the code number IR.JUMS.REC.1402.057. The informed consent was signed by each participant. Parents or legal guardians provided informed permission for individuals under the age of sixteen. We adhered to all of the World Medical Association Declaration of Helsinki's ethical guidelines for doing research on human subjects in medicine. Participants received assurances that the confidentiality of their data will be protected by Iran's data protection laws during processing. Consent of publication Not applicable. Competing intrests The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement The datasets created and examined for this research can be obtained by reaching out to the corresponding author.